Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
May
12
2017
NanoImpact Publishes Special Issue Based on Eighth International Congress of Nanotoxicology Bergeson & Campbell, P.C.
May
11
2017
FDA Adds Nine More New Substances to its Inventory of Effective FCS Notifications Keller and Heckman LLP
May
10
2017
Commissioner Scott Gottlieb’s Priorities as Newly Approved FDA Commissioner Epstein Becker & Green, P.C.
May
10
2017
EPA Will Delay Effective Date of TSCA Section 8(a) Rule Concerning Nanoscale Materials Bergeson & Campbell, P.C.
May
10
2017
Three Ways to Deal with FDA Calorie Labeling Delay ArentFox Schiff LLP
May
10
2017
USDA Further Delays Effective Date for Organic Livestock and Poultry Practices Rule Keller and Heckman LLP
May
9
2017
Does Southern Hemisphere Rugby Have A Recreational Drug Problem? Squire Patton Boggs (US) LLP
May
9
2017
More Sweetened Beverage Taxes Proposed As Voters Reject Others Keller and Heckman LLP
May
9
2017
Are Secret Sales Prior Art Under The AIA? Foley & Lardner LLP
May
8
2017
Joint Research Center Publishes NANoREG Framework for the Safety Assessment of Nanomaterials Bergeson & Campbell, P.C.
May
8
2017
Texas Supreme Court Weighs In on Tied House McDermott Will & Emery
May
8
2017
NSF Int’l Launches “Raised Without Antibiotics” Certification Keller and Heckman LLP
May
6
2017
ACS Publishes Study Finding that Nanoparticles Can Travel from Lungs to Blood, Possibly Explaining Risks to Heart Bergeson & Campbell, P.C.
May
5
2017
FDA Removes Clearance for Potassium Perchlorate in Sealing Gaskets Based on Abandonment Keller and Heckman LLP
May
5
2017
New York City Wins Battle Over Sodium Warning Requirements Keller and Heckman LLP
May
5
2017
EU Policy Update, May 2017: Brexit and European Elections; Tech and Digital Single Market; Communication and Media; Energy and Environment; Internal Market and Financial Services; Life Sciences and Healthcare; Trade Policy and Sanctions Covington & Burling LLP
May
4
2017
NanoMONITOR Begins Survey to Refine Design of Real-Time Information and Monitoring System Bergeson & Campbell, P.C.
May
4
2017
TSCA Import Certification Requirements Amended Keller and Heckman LLP
May
4
2017
USDA Eases Sodium Restrictions for School Meal Programs Keller and Heckman LLP
May
3
2017
The Responsible Corporate Officer Doctrine in the Wake of DeCoster Cadwalader, Wickersham & Taft LLP
May
3
2017
Implementation of Alternative Testing Strategies under Amended TSCA Bergeson & Campbell, P.C.
May
3
2017
What’s on the Menu Today, FDA? Morgan, Lewis & Bockius LLP
May
3
2017
“Healthy” Update: Industry, Others Weigh In on ‘Healthy’ Claims Keller and Heckman LLP
May
2
2017
Nearly Instantaneous Crop Data from Drones Polsinelli PC
May
2
2017
FDA Formally Extends Menu Labeling Compliance Date to 2018 Keller and Heckman LLP
May
2
2017
How Will The Supreme Court Choreograph The Biosimilar Patent Dance? Foley & Lardner LLP
May
2
2017
Breaking Down Barriers Between Pre-clinical and Clinical Adoption of Personalized Medicine Foley & Lardner LLP
May
1
2017
Appropriations Rider Halts FDA’s Voluntary Sodium Reduction Efforts Michael Best & Friedrich LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins